Search
Close this search box.

HIV Management Guide for Clinical Care

HIV Management Guide for Clinical Care

Search
Close this search box.

Other HIV-Associated Disease

Management > Other HIV-Associated Disease > References

Sections

Sections

References

  1. Espinoza LR, Garcia-Valladares I. Of bugs and joints: the relationship between infection and joints. Reumatol Clin. 2013;9(4):229-38.
  2. Lin TY, Yang CJ, Liu CE, Tang HJ, Chen TC, Chen GJ, et al. Clinical features of acute human immunodeficiency virus infection in Taiwan: A multicenter study. J Microbiol Immunol Infect. 2018.
  3. Lawson E, Walker-Bone K. The changing spectrum of rheumatic disease in HIV infection. Br Med Bull. 2012;103(1):203-21.
  4. Kole AK, Roy R, Kole DC. Musculoskeletal and rheumatological disorders in HIV infection: Experience in a tertiary referral center. Indian J Sex Transm Dis AIDS. 2013;34(2):107-12.
  5. Vassilopoulos D, Calabrese LH. Rheumatologic manifestations of HIV-1 and HTLV-1 infections. Cleve Clin J Med. 1998;65(8):436-41.
  6. Adizie T, Moots RJ, Hodkinson B, French N, Adebajo AO. Inflammatory arthritis in HIV positive patients: A practical guide. BMC Infect Dis. 2016;16:100.
  7. Larcher R, Mauboussin JM, Rouanet I, Sotto A. Early-developed hand osteoarthritis in treated HIV-positive patients: Four cases. Joint Bone Spine. 2015;82(5):365-7.
  8. Berman A, Espinoza LR, Diaz JD, Aguilar JL, Rolando T, Vasey FB, et al. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med. 1988;85(1):59-64.
  9. Berman A, Reboredo G, Spindler A, Lasala ME, Lopez H, Espinoza LR. Rheumatic manifestations in populations at risk for HIV infection: the added effect of HIV. J Rheumatol. 1991;18(10):1564-7.
  10. Fox C, Walker-Bone K. Evolving spectrum of HIV-associated rheumatic syndromes. Best Pract Res Clin Rheumatol. 2015;29(2):244-58.
  11. Mody GM, Parke FA, Reveille JD. Articular manifestations of human immunodeficiency virus infection. Best Pract Res Clin Rheumatol. 2003;17(2):265-87.
  12. Hamdulay SS, Glynne SJ, Keat A. When is arthritis reactive? Postgrad Med J. 2006;82(969):446-53.
  13. Calabrese LH, Kirchner E, Shrestha R. Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum. 2005;35(3):166-74.
  14. Mason E, Wray L, Foster R, Jamil MS, Guy R, McNulty A, et al. Reactive arthritis at the Sydney Sexual Health Centre 1992-2012: declining despite increasing chlamydia diagnoses. Int J STD AIDS. 2016;27(10):882-9.
  15. Dubrocq G, Estrada A, Kelly S, Rakhmanina N. Acute development of Cushing syndrome in an HIV-infected child on atazanavir/ritonavir based antiretroviral therapy. Endocrinol Diabetes Metab Case Rep. 2017;2017.
  16. Ceccarelli M, Venanzi Rullo E, Vaccaro M, Facciola A, d’Aleo F, Paolucci IA, et al. HIV-associated psoriasis: Epidemiology, pathogenesis, and management. Dermatol Ther. 2019;32(2):e12806.
  17. Alpalhao M, Borges-Costa J, Filipe P. Psoriasis in HIV infection: an update. Int J STD AIDS. 2019;30(6):596-604.
  18. Bartos G, Cline A, Beroukhim K, Burrall BA, Feldman SR. Current biological therapies for use in HIV-positive patients with psoriasis: case report of gesulkumab used and review. Dermatol Online J. 2018;24(11).
  19. Nicholson P, Saunsbury E, D’Angelo S, Churchill D, Walker-Bone K. Prevalence of and risk factors for gout in HIV-positive adults: A case-control study. Int J STD AIDS. 2019;30(3):249-55.
  20. Walker UA, Hoffmann C, Enters M, Thoden J, Behrens G, Mitzel SL. High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters. AIDS. 2006;20(11):1556-8.
  21. Eyer-Silva Wde A, Salgado MC, Pinto JF, Ferry FR, Neves-Motta R, Azevedo MC, et al. Acute gouty arthritis as a manifestation of immune reconstitution inflammatory syndrome after initiation of antiretroviral therapy. Rev Inst Med Trop Sao Paulo. 2012;54(4):231-3.
  22. du Toit R, Whitelaw D, Taljaard JJ, du Plessis L, Esser M. Lack of specificity of anticyclic citrullinated peptide antibodies in advanced human immunodeficiency virus infection. J Rheumatol. 2011;38(6):1055-60.
  23. Bijlsma JW, Derksen RW, Huber-Bruning O, Borleffs JC. Does AIDS ‘cure’ rheumatoid arthritis? Ann Rheum Dis. 1988;47(4):350-1.
  24. Cunha BM, Mota LM, Pileggi GS, Safe IP, Lacerda MV. HIV/AIDS and rheumatoid arthritis. Autoimmun Rev. 2015;14(5):396-400.
  25. Carroll MB, Fields JH, Clerc PG. Rheumatoid arthritis in patients with HIV: management challenges. Open Access Rheumatol. 2016;8:51-9.
  26. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387(10013):53-60.
  27. Mehsen-Cetre N, Cazanave C. Osteoarticular manifestations associated with HIV infection. Joint Bone Spine. 2017;84(1):29-33.
  28. Gedmintas L, Solomon DH. HIV and its effects on bone: a primer for rheumatologists. Curr Opin Rheumatol. 2012;24(5):567-75.
  29. Lin CA, Kuo AC, Takemoto S. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty. J Bone Joint Surg Am. 2013;95(11):1028-36.
  30. Ghrenassia E, Martis N, Boyer J, Burel-Vandenbos F, Mekinian A, Coppo P. The diffuse infiltrative lymphocytosis syndrome (DILS). A comprehensive review. J Autoimmun. 2015;59:19-25.
  31. Nguyen BY, Reveille JD. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Curr Opin Rheumatol. 2009;21(4):404-10.
  32. Reveille JD, Williams FM. Infection and musculoskeletal conditions: Rheumatologic complications of HIV infection. Best Pract Res Clin Rheumatol. 2006;20(6):1159-79.
  33. Guillevin L. Infections in vasculitis. Best Pract Res Clin Rheumatol. 2013;27(1):19-31.
  34. Patel N, Patel N, Khan T, Patel N, Espinoza LR. HIV infection and clinical spectrum of associated vasculitides. Curr Rheumatol Rep. 2011;13(6):506-12.
  35. Mody GM, Patel N, Budhoo A, Dubula T. Concomitant systemic lupus erythematosus and HIV: case series and literature review. Semin Arthritis Rheum. 2014;44(2):186-94.
  36. Liao HY, Tao CM, Su J. Concomitant systemic lupus erythematosus and HIV infection: A rare case report and literature review. Medicine (Baltimore). 2017;96(51):e9337.
  37. Sena Corrales G, Mora Navas L, Palacios Munoz R, Garcia Lopez V, Marquez Solero M, Santos Gonzalez J. Gonococcal arthritis in human immunodeficiency virus-infected patients. Review of the literature. Reumatol Clin. 2017;13(1):39-41.
  38. Takhar SS, Hendey GW. Orthopedic illnesses in patients with HIV. Emerg Med Clin North Am. 2010;28(2):335-42, Table of Contents.
  39. Chen WL, Lin YF, Tsai WC, Tsao YT. Unveiling tuberculous pyomyositis: an emerging role of immune reconstitution inflammatory syndrome. Am J Emerg Med. 2009;27(2):251 e1-2.
  40. Wood BR, Buitrago MO, Patel S, Hachey DH, Haneuse S, Harrington RD. Mycobacterium avium Complex Osteomyelitis in Persons With Human Immunodeficiency Virus: Case Series and Literature Review. Open Forum Infect Dis. 2015;2(3):ofv090.
  41. Bi S, Hu FS, Yu HY, Xu KJ, Zheng BW, Ji ZK, et al. Nontuberculous mycobacterial osteomyelitis. Infect Dis (Lond). 2015;47(10):673-85.
  42. Noe MM, Jain AG, Shahid S, Majeed U. Severe Rhabdomyolysis as an Unusual Presentation of Primary Human Immunodeficiency Virus Infection. Cureus. 2018;10(7):e3041.
  43. Johnson RW, Williams FM, Kazi S, Dimachkie MM, Reveille JD. Human immunodeficiency virus-associated polymyositis: a longitudinal study of outcome. Arthritis Rheum. 2003;49(2):172-8.
  44. Lloyd TE, Pinal-Fernandez I, Michelle EH, Christopher-Stine L, Pak K, Sacktor N, et al. Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients. Neurology. 2017;88(15):1454-60.
  45. Landon-Cardinal O, Gallay L, Dubourg O, Maisonobe T, Leonard-Louis S, Beniken D, et al. Expanding the spectrum of HIV-associated myopathy. J Neurol Neurosurg Psychiatry. 2019.
  46. Lacomis D. What is in the Myopathy Literature? J Clin Neuromuscul Dis. 2018;19(4):217-23.
  47. Lazarou IN, Guerne PA. Classification, diagnosis, and management of idiopathic inflammatory myopathies. J Rheumatol. 2013;40(5):550-64.
  48. Schnitzler LJ, Schreckenbach T, Nadaj-Pakleza A, Stenzel W, Rushing EJ, Van Damme P, et al. Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases. Orphanet J Rare Dis. 2017;12(1):86.
  49. Mani D, Aboulafia DM. Editorial comment: HIV-associated adult-onset nemaline myopathy. AIDS Read. 2008;18(2):100-1.
  50. Margolis AM, Heverling H, Pham PA, Stolbach A. A review of the toxicity of HIV medications. J Med Toxicol. 2014;10(1):26-39.
  51. Chastain DB, Stover KR, Riche DM. Evidence-based review of statin use in patients with HIV on antiretroviral therapy. J Clin Transl Endocrinol. 2017;8:6-14.

Developing a sustainable HIV, Viral Hepatitis and Sexual Health Workforce

Information

About ASHMFeedback
Glossary of TermsPrivacy Policy
AcknowledgementsDisclosure Statements

Acknowledgement of Country

We pay our respects to the Aboriginal and Torres Strait Islander peoples of the past, present, and future, including the Gadigal peoples (Sydney office), the Turrbal and Jagera/Yuggera peoples (Brisbane office), and all First Nations people of the nations where we live and work.

ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM

Scroll to Top